DNA Methylation in Alzheimer's Disease
- PMID: 39455499
- DOI: 10.1007/7854_2024_530
DNA Methylation in Alzheimer's Disease
Abstract
To date, DNA methylation is the best characterized epigenetic modification in Alzheimer's disease. Involving the addition of a methyl group to the fifth carbon of the cytosine pyrimidine base, DNA methylation is generally thought to be associated with the silencing of gene expression. It has been hypothesized that epigenetics may mediate the interaction between genes and the environment in the manifestation of Alzheimer's disease, and therefore studies investigating DNA methylation could elucidate novel disease mechanisms. This chapter comprehensively reviews epigenomic studies, undertaken in human brain tissue and purified brain cell types, focusing on global methylation levels, candidate genes, epigenome wide approaches, and recent meta-analyses. We discuss key differentially methylated genes and pathways that have been highlighted to date, with a discussion on how new technologies and the integration of multiomic data may further advance the field.
Keywords: Alzheimer’s disease; Brain cell types; Brain tissue; DNA methylation; Epigenetics.
© 2024. The Author(s), under exclusive license to Springer Nature Switzerland AG.
References
-
- Alonso C, Palomares Y (2021) Playing with genetic and epigenetic concepts at the school: an epigenetic orchestra project. Evol Educ Outreach 14(1):6
-
- Alzheimer A, Stelzmann RA, Schnitzlein HN, Murtagh FR (1995) An English translation of Alzheimer’s 1907 paper, “Uber eine eigenartige Erkankung der Hirnrinde”. Clin Anat 8(6):429–431 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
